Lionheart

Lionheart Health is a biotechnology company specializing in bioelectric medicine and regenerative therapies aimed at organ repair and longevity. The company utilizes a proprietary bioelectric platform that delivers specific signaling sequences to stimulate the body's natural production of regenerative proteins, such as Klotho, Sonic Hedgehog, and VEGF. This technology is being developed for a wide range of clinical applications, including heart failure, chronic kidney disease, erectile dysfunction, and skin rejuvenation. Operating as part of the Leonhardt's Launchpads venture studio, Lionheart Health leverages decades of expertise in implantable medical devices and biologics. Their approach combines non-invasive bioelectric stimulation with targeted biologic therapies to promote tissue regeneration and extend healthy lifespan.